Hyped cannabis stock ACB finally worth a buy
Updated
After a long downward slide, Aurora Cannabis has finally hit a support critical level around $2.50. With the stock finally looking a little undervalued and a large recent earnings beat under its belt, ACB should rally higher. Call buyers are targeting $5.00 per share within two months, with over 40,000 call options located at that price. Cannabis is a hype sector, so when investor interest picks back up, it could quickly turn red hot. Several times in the last few years, ACB has hit over $10 per share.
Note
Instead of taking the 8% profit when I had the chance, I've been hanging onto this thinking it's a long-term trade. In the last couple days, however, a couple extremely bearish analyst reports have come out suggesting that the company is burning too much cash and that the stock may go to zero. I went ahead and exited for a 2% loss this morning.Note
There's more call-buying happening today as ACB attempts a double bottom. The balance of options trading is surprisingly bullish given how negative the analyst coverage was this week.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.